TKR: Periarticular injection of 0.25% bupivacaine reduces morphine consumption
TKR: Periarticular injection of 0.25% bupivacaine reduces morphine consumption
Periarticular Injection with Bupivacaine for Postoperative Pain Control in Total Knee Replacement: A Prospective Randomized Double-Blind Controlled Trial
Adv Orthop. 2012;2012:107309. doi: 10.1155/2012/107309. Epub 2012 Oct 22Did you know you're eligible to earn 0.5 CME credits for reading this report? Click Here
Synopsis
60 osteoarthritis patients undergoing total knee arthroplasty (TKA) were randomized to receive a periarticular injection of bupivacaine or saline prior to closure of the wound. Over the first 6 hours after surgery, patients in the bupivacaine group consumed significantly less morphine than the saline group. However, this difference was not significant between 6 and 96 hours after the operation. Th...
To view the full content, login to your account,
or start your 30-day FREE Trial today.
FREE TRIAL
LOGIN
Forgot Password?
Explore some of our unlocked ACE Reports below!

Learn about our AI Driven
High Impact Search Feature

Our AI driven High Impact metric calculates the impact an article will have by considering both the publishing journal and the content of the article itself. Built using the latest advances in natural language processing, OE High Impact predicts an article’s future number of citations better than impact factor alone.
Continue
Join the Conversation
Please Login or Join to leave comments.